Author

Nourhan Kahwaji

Berlin-Brandenburger Centrum für Regenerative TherapienORCID 0000-0002-9326-8529Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:non-human primate· 1 Approach:statistical model· 1

Frequent Co-Authors

Charlotte Maeve DunneiD· 2 shared Andriko PalmowskiiD· 1 shared Angela Fischer· 1 shared Anna Luisa HilleriD· 1 shared Ansgar Santel· 1 shared Antonia M Klaas· 1 shared Arnd KleyeriD· 1 shared Chantal PichoniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Charlotte Maeve DunneORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Translational Pharmacokinetics and Pharmacodynamics of a Cationic mRNA-Lipid Nanoparticle from Mice to Non-Human Primates

Charlotte Maeve Dunne, Katrin Radloff, Leonidas Gkionis, Nourhan Kahwaji, Natscha Hartl, Oliver Keil, Angela Fischer, Gerrit Maass, Ansgar Santel, Daniel Tondera, Jorg Kaufmann

This study evaluates the pharmacokinetics and immunostimulatory effects of a cationic mRNA-LNP in non-human primates, identifying a biomarker for Tie2 signaling.

bioRxiv · Sep 29, 2026 · PreprintPharmacology & Toxicology

Revisiting the need for mRNA nucleoside modification in CAR T cell engineering

Nourhan Kahwaji, Niklas Kotzian, Jasmin Melissa Prinz, Yaolin Pu, Jonas Kath, Samira Picht, Anna Luisa Hiller, Antonia M Klaas, Charlotte Maeve Dunne, Michael Launspach, Andriko Palmowski, Arnd Kleyer, David Simón, Dimitrios L. Wagner, Chantal Pichon, , Norman Michael Drzeniek

This study shows that unmodified mRNA can be used for CAR-T cell engineering without compromising function, eliminating the need for costly nucleoside modifications.

Molecular Therapy — Nucleic Acids · Jan 5, 2026Peer-reviewedBioengineering